Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 678 clinical trials
AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics (TRUST)

This study will evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of AZD7442 administered intramuscularly (IM) or intravenously (IV) in pediatric participants aged ≥ 29 weeks GA to < 18 years.

  • 0 views
  • 29 May, 2022
  • 2 locations
Evaluation and Comparison of One Day Discharge Versus Discharge Home 24 Hours After the Laparoscopic Appendectomy for Uncomplicated Appendicitis in Children

The aim of this study was to evaluate the value and safety of discharge of a child to home care within 24 hours after laparoscopic appendectomy for uncomplicated appendicitis to reduce the impact on the child's psyche and need for hospitalisation. This was compared to the previous treatment modality of …

  • 0 views
  • 05 Nov, 2021
  • 1 location
COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)

To evaluate if omalizumab is effective in decreasing mortality in severe hospitalized COVID-19 cases.

  • 0 views
  • 22 Mar, 2022
  • 3 locations
Changes in Capillary Carbon Dioxide Partial Pressure (pCO2) While Wearing FFP2 / FFP3 Masks

The aim of this study is to determine whether there are any changes in the carbon dioxide partial pressure in medical staff while wearing a filtering face piece (FFP) 2 or FFP3 mask. Furthermore, changes in the capillary oxygen partial pressure, the subjective respiratory effort and the breathing rate are …

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
  • 1 location
Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19

The purpose of this study is to evaluate the efficacy and safety of high/low-dose cepharanthine for the Treatment of COVID-19 in asymptomatic and non-pneumonia mild adult participants with COVID-19 who do not need to be in the hospital, but in alternate care site.

  • 0 views
  • 28 Jun, 2022
Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination (INFORMED)

This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED delivered by LHW educational outreach plus Short Message Service (SMS) text messaging to …

Accepts healthy volunteers
  • 0 views
  • 06 Mar, 2022
  • 1 location
Caregiving During Crisis

This study will test a prototype pandemic caregiver training and education course designed for caregivers of persons living with dementia (PLWD). Participants will be randomized to take the course immediately or to take the course after completion of an 8-week waiting period.

Accepts healthy volunteers
  • 0 views
  • 25 Mar, 2022
  • 1 location
Examination of The Effects of Telerehabilitation in Painful Healthcare Workers With and Without COVID-19 Infection

In the literature, there are studies examining the effects of telerehabilitation on individuals who have had COVID-19, but studies examining the effects on healthcare workers who have experienced COVID-19 are insufficient. In this study, which is planned to be done, it is aimed to examine the effects of myofascial relaxation …

Accepts healthy volunteers
  • 0 views
  • 18 Apr, 2022
Caregiving and Racial Considerations During a Pandemic Online Training Education (CaRE)

The overall goal of this project is to develop and prototype-test a highly accessible program designed to enhance the mastery of Black American caregivers to provide care to family members or friends living with a dementia illness in a time of crisis. Participants will be asked a series of questions …

  • 0 views
  • 22 Mar, 2022
  • 1 location
Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.

Colchicine acts upstream in the cytokines cascade by inhibiting the NLRP3 inflammasome while IL-6 receptor antagonists (tocilizumab) block the end result of the cytokines cascade. Hence, adding colchicine to tocilizumab with the aim of blocking the early and end products of the cytokines cascade, might reduce the risk of developing …

  • 0 views
  • 10 Dec, 2021
  • 1 location